Doris R. Siwak

2.5k total citations
27 papers, 1.7k citations indexed

About

Doris R. Siwak is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Doris R. Siwak has authored 27 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 8 papers in Oncology and 7 papers in Cancer Research. Recurrent topics in Doris R. Siwak's work include Monoclonal and Polyclonal Antibodies Research (5 papers), Advanced Biosensing Techniques and Applications (4 papers) and Advanced Proteomics Techniques and Applications (3 papers). Doris R. Siwak is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (5 papers), Advanced Biosensing Techniques and Applications (4 papers) and Advanced Proteomics Techniques and Applications (3 papers). Doris R. Siwak collaborates with scholars based in United States, Japan and Canada. Doris R. Siwak's co-authors include Gordon B. Mills, Razelle Kurzrock, Bharat B. Aggarwal, Shishir Shishodia, Yiling Lu, Justin M. Summy, David J. McConkey, Alan J. Kraker, Nila U. Parikh and T. Christopher Windham and has published in prestigious journals such as Nature Communications, Nature Genetics and Bioinformatics.

In The Last Decade

Doris R. Siwak

27 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Doris R. Siwak United States 18 1.2k 462 224 213 137 27 1.7k
Sally A. Prigent United Kingdom 16 775 0.7× 483 1.0× 114 0.5× 100 0.5× 188 1.4× 23 1.3k
Aruna Basu United States 19 1.2k 1.0× 690 1.5× 234 1.0× 196 0.9× 225 1.6× 23 1.9k
Kang Jin Jeong United States 23 1.3k 1.1× 492 1.1× 481 2.1× 145 0.7× 154 1.1× 32 1.7k
Amro Aboukameel United States 31 2.0k 1.7× 1.0k 2.2× 611 2.7× 166 0.8× 142 1.0× 91 2.8k
Jun Rao China 17 734 0.6× 386 0.8× 263 1.2× 108 0.5× 81 0.6× 42 1.2k
Anna Martínez‐Cardús Spain 23 1.3k 1.1× 813 1.8× 487 2.2× 189 0.9× 67 0.5× 48 1.9k
Mei‐Chih Liang United States 20 1.3k 1.1× 702 1.5× 429 1.9× 360 1.7× 201 1.5× 30 2.2k
Alexei V. Salnikov Germany 17 870 0.8× 802 1.7× 433 1.9× 153 0.7× 127 0.9× 23 1.6k
Fei-Meng Zheng China 20 1.1k 1.0× 484 1.0× 538 2.4× 136 0.6× 379 2.8× 33 1.7k

Countries citing papers authored by Doris R. Siwak

Since Specialization
Citations

This map shows the geographic impact of Doris R. Siwak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Doris R. Siwak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Doris R. Siwak more than expected).

Fields of papers citing papers by Doris R. Siwak

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Doris R. Siwak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Doris R. Siwak. The network helps show where Doris R. Siwak may publish in the future.

Co-authorship network of co-authors of Doris R. Siwak

This figure shows the co-authorship network connecting the top 25 collaborators of Doris R. Siwak. A scholar is included among the top collaborators of Doris R. Siwak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Doris R. Siwak. Doris R. Siwak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fujita, Masashi, Mei-Ju May Chen, Doris R. Siwak, et al.. (2022). Proteo-genomic characterization of virus-associated liver cancers reveals potential subtypes and therapeutic targets. Nature Communications. 13(1). 6481–6481. 13 indexed citations
2.
Iwaya, Takeshi, Noriyuki Sasaki, Masashi Fujita, et al.. (2021). Frequent post-operative monitoring of colorectal cancer using individualised ctDNA validated by multiregional molecular profiling. British Journal of Cancer. 124(9). 1556–1565. 7 indexed citations
3.
Sasaki, Noriyuki, Takeshi Iwaya, Masashi Fujita, et al.. (2020). Analysis of mutational and proteomic heterogeneity of gastric cancer suggests an effective pipeline to monitor post-treatment tumor burden using circulating tumor DNA. PLoS ONE. 15(10). e0239966–e0239966. 4 indexed citations
4.
Siwak, Doris R., Jun Li, Rehan Akbani, Han Liang, & Yiling Lu. (2019). Analytical Platforms 3: Processing Samples via the RPPA Pipeline to Generate Large-Scale Data for Clinical Studies. Advances in experimental medicine and biology. 1188. 113–147. 12 indexed citations
5.
Fan, Ping, et al.. (2019). Suppression of Nuclear Factor-κB by Glucocorticoid Receptor Blocks Estrogen-Induced Apoptosis in Estrogen-Deprived Breast Cancer Cells. Molecular Cancer Therapeutics. 18(10). 1684–1695. 20 indexed citations
6.
Annis, Matthew G., Patricia MacDonald, Caterina Russo, et al.. (2019). GPNMB augments Wnt-1 mediated breast tumor initiation and growth by enhancing PI3K/AKT/mTOR pathway signaling and β-catenin activity. Oncogene. 38(26). 5294–5307. 36 indexed citations
7.
Dupuy, Fanny, Takla Griss, Julianna Blagih, et al.. (2013). LKB1 is a central regulator of tumor initiation and pro-growth metabolism in ErbB2-mediated breast cancer. Cancer & Metabolism. 1(1). 18–18. 39 indexed citations
8.
Irwin, Mary E., Laura D. Nelson, Claudia P. Miller, et al.. (2013). Small Molecule ErbB Inhibitors Decrease Proliferative Signaling and Promote Apoptosis in Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia. PLoS ONE. 8(8). e70608–e70608. 18 indexed citations
9.
Wheeler, Sarah, Doris R. Siwak, Raymond L. Chai, et al.. (2012). Tumor Epidermal Growth Factor Receptor and EGFR PY1068 Are Independent Prognostic Indicators for Head and Neck Squamous Cell Carcinoma. Clinical Cancer Research. 18(8). 2278–2289. 63 indexed citations
10.
Nikolova, Dessislava A., Irfan A. Asangani, Laura D. Nelson, et al.. (2009). Cetuximab Attenuates Metastasis and u-PAR Expression in Non–Small Cell Lung Cancer: u-PAR and E-Cadherin are Novel Biomarkers of Cetuximab Sensitivity. Cancer Research. 69(6). 2461–2470. 23 indexed citations
11.
Grote, Tobias, Doris R. Siwak, Herbert A. Fritsche, et al.. (2008). Validation of reverse phase protein array for practical screening of potential biomarkers in serum and plasma: Accurate detection of CA19‐9 levels in pancreatic cancer. PROTEOMICS. 8(15). 3051–3060. 66 indexed citations
12.
Aoki, Hiroshi, Eiji Iwado, Mark S. Eller, et al.. (2007). Telomere 3′ overhang‐specific DNA oligonucleotides induce autophagy in malignant glioma cells. The FASEB Journal. 21(11). 2918–2930. 58 indexed citations
13.
Amit, Ido, Ami Citri, Tal Shay, et al.. (2007). A module of negative feedback regulators defines growth factor signaling. Nature Genetics. 39(4). 503–512. 360 indexed citations
14.
Tibes, Raoul, Yiling Lu, Doris R. Siwak, et al.. (2005). Identification of selective inhibition of phospho-S6 ribosomal protein in XK469 sensitive leukemia cell lines using functional proteomic analysis. Cancer Research. 65. 772–772. 2 indexed citations
15.
16.
Mendoza-Gamboa, Edgar, Doris R. Siwak, & Ana M. Tari. (2004). The HER2/Grb2/Akt pathway regulates the DNA binding activity of AP-1 in breast cancer cells. Oncology Reports. 12(4). 903–8. 7 indexed citations
17.
Zang, Xiaoping, et al.. (2004). KGF-induced motility of breast cancer cells is dependent on Grb2 and Erk1,2. Clinical & Experimental Metastasis. 21(5). 437–443. 21 indexed citations
18.
Siwak, Doris R., Ana M. Tari, & Gabriel Lopez‐Berestein. (2004). Liposomal Antisense Oligonucleotides for Cancer Therapy. Methods in enzymology on CD-ROM/Methods in enzymology. 387. 241–253. 5 indexed citations
19.
Siwak, Doris R., Ana M. Tari, & Gabriel Lopez‐Berestein. (2002). The potential of drug-carrying immunoliposomes as anticancer agents. Commentary re: J. W. Park et al., Anti-HER2 immunoliposomes: enhanced efficacy due to targeted delivery. Clin. Cancer Res., 8: 1172-1181, 2002.. PubMed. 8(4). 955–6. 37 indexed citations
20.
Windham, T. Christopher, Nila U. Parikh, Doris R. Siwak, et al.. (2002). Src activation regulates anoikis in human colon tumor cell lines. Oncogene. 21(51). 7797–7807. 173 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sally A. Prigent Breakdown of academic impact, for papers by Aruna Basu Breakdown of academic impact, for papers by Kang Jin Jeong Breakdown of academic impact, for papers by Amro Aboukameel Breakdown of academic impact, for papers by Jun Rao Breakdown of academic impact, for papers by Anna Martínez‐Cardús Breakdown of academic impact, for papers by Mei‐Chih Liang Breakdown of academic impact, for papers by Alexei V. Salnikov Breakdown of academic impact, for papers by Fei-Meng Zheng
Rankless by CCL
2026